Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia
Status:
Recruiting
Trial end date:
2025-05-30
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, single-arm, phase 2 trial. The aim of this study is to
evaluate the efficacy and safety of herombopag combined with cyclosporine for patients with
non severe aplastic anemia (NSAA).